InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Finn Patrick John. Director active across 1 company, notably Twist Bioscience Corp. Cumulatively, 2 reports have been logged. Activity tracked since 23 July 2026. The latest transaction was disclosed on 3 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations